These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 34674906)
1. The costs incurred by the NHS in England due to the unnecessary prescribing of dependency-forming medications. Davies J; Cooper RE; Moncrieff J; Montagu L; Rae T; Parhi M Addict Behav; 2022 Feb; 125():107143. PubMed ID: 34674906 [TBL] [Abstract][Full Text] [Related]
2. Medicines associated with dependence or withdrawal: a mixed-methods public health review and national database study in England. Marsden J; White M; Annand F; Burkinshaw P; Carville S; Eastwood B; Kelleher M; Knight J; O'Connor R; Tran A; Willey P; Greaves F; Taylor S Lancet Psychiatry; 2019 Nov; 6(11):935-950. PubMed ID: 31588045 [TBL] [Abstract][Full Text] [Related]
3. Trends and variation in prescribing of low-priority treatments identified by NHS England: a cross-sectional study and interactive data tool in English primary care. Walker AJ; Curtis HJ; Bacon S; Croker R; Goldacre B J R Soc Med; 2018 Jun; 111(6):203-213. PubMed ID: 29787684 [TBL] [Abstract][Full Text] [Related]
4. Surging trends in prescriptions and costs of antidepressants in England amid COVID-19. Rabeea SA; Merchant HA; Khan MU; Kow CS; Hasan SS Daru; 2021 Jun; 29(1):217-221. PubMed ID: 33715138 [TBL] [Abstract][Full Text] [Related]
5. Do doctors in dispensing practices with a financial conflict of interest prescribe more expensive drugs? A cross-sectional analysis of English primary care prescribing data. Goldacre B; Reynolds C; Powell-Smith A; Walker AJ; Yates TA; Croker R; Smeeth L BMJ Open; 2019 Feb; 9(2):e026886. PubMed ID: 30813120 [TBL] [Abstract][Full Text] [Related]
6. Effect of fundholding and indicative prescribing schemes on general practitioners' prescribing costs. Bradlow J; Coulter A BMJ; 1993 Nov; 307(6913):1186-9. PubMed ID: 8251847 [TBL] [Abstract][Full Text] [Related]
7. UK interventions to control medicines wastage: a critical review. White KG Int J Pharm Pract; 2010 Jun; 18(3):131-40. PubMed ID: 20509346 [TBL] [Abstract][Full Text] [Related]
8. Effects of the National Institute for Health and Clinical Excellence's technology appraisals on prescribing and net ingredient costs of drugs in the National Health Service in England. Dietrich ES Int J Technol Assess Health Care; 2009 Jul; 25(3):262-71. PubMed ID: 19619344 [TBL] [Abstract][Full Text] [Related]
10. What is the cost of atopic dermatitis in preschool children? Emerson RM; Williams HC; Allen BR Br J Dermatol; 2001 Mar; 144(3):514-22. PubMed ID: 11260008 [TBL] [Abstract][Full Text] [Related]
11. Special Low Protein Foods Prescribed in England for PKU Patients: An Analysis of Prescribing Patterns and Cost. Wood G; Pinto A; Evans S; Daly A; Adams S; Costelloe S; Gribben J; Ellerton C; Emm A; Firman S; Ford S; French M; Gaff L; Giuliano E; Hill M; Hunjan I; Newby C; Mackenzie A; Pereira R; Prescott C; Robertson L; Seabert H; Skeath R; Tapley S; Terry A; Tooke A; van Wyk K; White FJ; White L; Woodall A; Rocha JC; MacDonald A Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836232 [TBL] [Abstract][Full Text] [Related]
12. Long-Term Costs and Health Consequences of Issuing Shorter Duration Prescriptions for Patients with Chronic Health Conditions in the English NHS. Martin A; Payne R; Wilson EC Appl Health Econ Health Policy; 2018 Jun; 16(3):317-330. PubMed ID: 29532329 [TBL] [Abstract][Full Text] [Related]
13. Attitudes and behaviour of general practitioners and their prescribing costs: a national cross sectional survey. Watkins C; Harvey I; Carthy P; Moore L; Robinson E; Brawn R Qual Saf Health Care; 2003 Feb; 12(1):29-34. PubMed ID: 12571342 [TBL] [Abstract][Full Text] [Related]
14. Lost cost savings to the NHS in England due to the delayed entry of multiple generic low-dose transdermal buprenorphine: a case scenario analysis. Chapman SR; Aladul MI; Fitzpatrick RW BMJ Open; 2019 Aug; 9(8):e026817. PubMed ID: 31375605 [TBL] [Abstract][Full Text] [Related]
15. Trends in gabapentinoid prescribing, co-prescribing of opioids and benzodiazepines, and associated deaths in Scotland. Torrance N; Veluchamy A; Zhou Y; Fletcher EH; Moir E; Hebert HL; Donnan PT; Watson J; Colvin LA; Smith BH Br J Anaesth; 2020 Aug; 125(2):159-167. PubMed ID: 32571568 [TBL] [Abstract][Full Text] [Related]
16. The prevalence and prescribing patterns of benzodiazepines and Z-drugs in older nursing home residents in different European countries and Israel: retrospective results from the EU SHELTER study. Lukačišinová A; Fialová D; Peel NM; Hubbard RE; Brkic J; Onder G; Topinková E; Gindin J; Shochat T; Gray L; Bernabei R BMC Geriatr; 2021 Apr; 21(1):277. PubMed ID: 33902474 [TBL] [Abstract][Full Text] [Related]
17. Estimating the cost of smoking to the NHS in England and the impact of declining prevalence. Callum C; Boyle S; Sandford A Health Econ Policy Law; 2011 Oct; 6(4):489-508. PubMed ID: 20735898 [TBL] [Abstract][Full Text] [Related]
18. Dispensations of benzodiazepines, z-hypnotics, and gabapentinoids to patients receiving opioid agonist therapy; a prospective cohort study in Norway from 2013 to 2017. Vold JH; Skurtveit S; Aas C; Chalabianloo F; Kloster PS; Johansson KA; Fadnes LT BMC Health Serv Res; 2020 Apr; 20(1):352. PubMed ID: 32334602 [TBL] [Abstract][Full Text] [Related]
19. Suboptimal prescribing behaviour associated with clinical software design features: a retrospective cohort study in English NHS primary care. MacKenna B; Curtis HJ; Walker AJ; Bacon S; Croker R; Goldacre B Br J Gen Pract; 2020 Sep; 70(698):e636-e643. PubMed ID: 32784218 [TBL] [Abstract][Full Text] [Related]